Bangkok--17 May--Media Planner Consultants
DOD Biotech Pcl., or DOD, the leading Original Design Manufacturer (ODM) of dietary supplements under the ISO22000:2005, HACCP, GMP Codex, and HALAL standards, providing a complete services of One Stop Service, prepared its issuance of 110 million additional ordinary shares with a par value of 0.50 baht and the proceed was to invest in raw material extract plant (Plant 2), international standard lab, and the Company's new brand development. With confidence of Advisory Plus Co., Ltd., the financial advisor, and KT Zmico Securities Co., Ltd., the lead under writer that the shares would be listed on the mai in the middle of this year.
Miss Supamas Isarabhakdi, Managing Director of DOD Biotech Pcl., or DOD disclosed that DOD was the manufacturer of dietary supplement products of which main components came from natural extract, providing complete service of One Stop Service ranging from research and development of dietary supplement formula following needs of customers, food serial number registration, product and packaging design, marketing consultant service and distribution channel provision service, as well as manufacturing and international standardized manufacturing quality control. All dietary supplementary products under brands produced by the Company's plants received a complete and accurate food serial number registration from the Thai Food and Drug Administration (Thai FDA) - 1 food serial number for one brand. Thus, the consumers could be confident with the standard and safety of the products.
The Company placed an importance on research and development since they were an important part in the success of the ODM of dietary supplementary. The Company's research and development team had experiences in research and development of herb dietary supplementary products which helped strengthen and sustainable growth of the business as well as enhance the standard of Thai herbal plants. The Company received technology and Know-How of extracting to receive important required components with efficiency for the maximum effectiveness of the products.
In addition, the Company had improved its manufacturing standard within the Clean Room which was the same manufacturing standard as medical product manufacturing, indicating the Company's emphasis on product quality and safety for the consumers.
CHIEF EXECUTIVE and Managing Director of DOD Biotech Pcl., added that the proceed, after the capital raising of DOD, would be used for investment in the raw material extract plant (Plant 2) to extract important components for dietary supplement manufacturing as well as to extract for local distribution and export, and for investment in the international standard lab with the certification of ISO 17025 which could examine the specific quality of the extracted substances from the extract plant, provide services of chemical and microbiological examination to other agencies, and maintain trading secrecy. In addition, the proceed also went to the development of the Company's new brands such as the products for the elderly with the focus on good health, and the herbal Triphala product with the focus on body's function recovery, digestive system and excretory system. Moreover, the proceeds would be used for the repayment to financial institutions and working capital of the business.
"With our business goal to be the leader of ODM for high quality dietary supplement products focusing on beauty and health originated from continuous research and development
following the international standards, DOD has continued its Thai natural extract research in order to develop manufacturing innovation of new products to establish the growth and sustainability of the industry", said Miss Supamas.
Mrs.Nisaporn Rerkaram President Advisory Plus Co., Ltd, the financial advisor of the share listing on the mai of DOD Biotech Pcl., under the symbol "DOD", said that the Company had prepared the issuance of 110 million additional ordinary shares for the Initial Public Offering (IPO), accounting for 26.83% of the issued and paid-up capitals after the capital raising. At present, the Company's paid-up capitals were at 150 million baht, accounting for 300 million shares at the par value of 0.50 baht. The Company would increase its registered capitals to 205 million baht, accounting for 410 million shares through the issuance of additional ordinary shares of 110 million baht for the IPO. Recently, the Company received the approval from the Securities and Exchange Commission Office (SEC) to issue the additional ordinary shares.
The Company's past operating results from 2015 to the recent Q1/2018 had shown a continuous growth with a jump performance. In 2015, the total revenue was at 385.36 million baht and the net profit of 128.89 million baht; in 2016, the total revenue was at 368.37 million baht and the net profit of 138.78 million baht; in 2017, the total revenue was at 388.56 baht and the net profit of 142.19 million baht; and the operating results of the recent Q1/ 2018 had the total revenue 214.56 million baht and the net profit of 111.21 million baht. Those performances had reflected the Company's potential of continuous business expansion. In addition, the Company had the dividend payment policy to the shareholders of no less than 50% of the net profit.
Mr. Khomklit Meekumsat Executive Vice President , KT Zmico Securities Co., Ltd, the lead underwriter, informed that at the initial stage there would be a roadshow to provide information to institutional and general investors and the subscription of the shares as well as the listing of the shares on the mai would be definitely implemented in the middle of this year.